Utilization of Oncotype DX in an Inner City Population: Race or Place?

Oncotype DX, a 21-gene-array analysis, can guide chemotherapy treatment decisions for women with ER+ tumors. Of 225 ER+ women participating in a patient assistance trial, 23% underwent Oncotype DX testing: 31% of whites, 21% of blacks, and 14% of Hispanics (P = 0.04) were tested. Only 3 white women...

Descripción completa

Detalles Bibliográficos
Autores principales: Guth, Amber A., Fineberg, Susan, Fei, Kezhen, Franco, Rebeca, Bickell, Nina A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878389/
https://www.ncbi.nlm.nih.gov/pubmed/24455283
http://dx.doi.org/10.1155/2013/653805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878389/
https://www.ncbi.nlm.nih.gov/pubmed/24455283
http://dx.doi.org/10.1155/2013/653805

Ejemplares similares